KIP Infrastructure
2.12.0 - ci-build
KIP Infrastructure, published by Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S. This guide is not an authorized publication; it is the continuous build for version 2.12.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/KIP-infrastructure/implementation-guide/ and changes regularly. See the Directory of published versions
| Active as of 2022-06-14 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="ATCChemoPreparation"/>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet ATCChemoPreparation</b></p><a name="ATCChemoPreparation"> </a><a name="hcATCChemoPreparation"> </a><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <a href="CodeSystem-ATC.html"><code>https://kip.rkkp.dk/fhir/CodeSystem/ATC</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01BC02">L01BC02</a></td><td>Fluorouracil (5-FU)</td><td>L01BC02 - Fluorouracil (5-FU)</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01BC05">L01BC05</a></td><td>Gemcitabine</td><td>L01BC02 - Gemcitabine</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01BC06">L01BC06</a></td><td>Capecitabine</td><td>L01BC06 - Capecitabine</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01CA04">L01CA04</a></td><td>Vinorelbine</td><td>L01CA04 - Vinorelbine</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01CD01">L01CD01</a></td><td>Paclitaxel</td><td>L01CD01 - Paclitaxel</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01CD02">L01CD02</a></td><td>Docetaxel</td><td>L01CD02 - Docetaxel</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01CE02">L01CE02</a></td><td>Irinotecan</td><td>L01CE02 - Irinotecan</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01DB01">L01DB01</a></td><td>Doxorubicin</td><td>L01DB01 - Doxorubicin</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01DB03">L01DB03</a></td><td>Epirubicin</td><td>L01DB03 - Epirubicin</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01FD01">L01FD01</a></td><td>Trastuzumab</td><td>L01FD01 - Trastuzumab</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01FF01">L01FF01</a></td><td>Nivolumab</td><td>L01FF01 - Nivolumab</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01FF02">L01FF02</a></td><td>Pembrolizumab</td><td>L01FF02 - Pembrolizumab</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01FG01">L01FG01</a></td><td>Bevacizumab</td><td>L01FG01 - Bevacizumab</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01XA01">L01XA01</a></td><td>Cisplatin</td><td>L01XA01 - Cisplatin</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01XA02">L01XA02</a></td><td>Carboplatin</td><td>L01XA02 - Carboplatin</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01XA03">L01XA03</a></td><td>Oxaliplatin</td><td>L01XA03 - Oxaliplatin</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-S01LA08">S01LA08</a></td><td>Bevacizumab</td><td>S01LA08 - Bevacizumab</td></tr></table></li><li>Include these codes as defined in <a href="CodeSystem-GenericValues.html"><code>https://kip.rkkp.dk/fhir/CodeSystem/GenericValues</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href="CodeSystem-GenericValues.html#GenericValues-other">other</a></td><td>Andet</td><td>Other - used to choose unspecific value not in a valueset</td></tr></table></li></ul></div>
</text>
<url value="https://kip.rkkp.dk/fhir/ValueSet/ATCChemoPreparation"/>
<version value="2.12.0"/>
<name value="ATCChemoPreparation"/>
<title value="ATC: Præparater for kemobehandling"/>
<status value="active"/>
<experimental value="true"/>
<date value="2022-06-14T00:00:00+02:00"/>
<publisher
value="Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S"/>
<contact>
<name
value="Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S"/>
<telecom>
<system value="url"/>
<value value="https://trifork.com"/>
</telecom>
<telecom>
<system value="email"/>
<value value="rbk@trifork.com"/>
</telecom>
</contact>
<description value="ATC koder for præparater for kemobehandling"/>
<compose>
<include>
<system value="https://kip.rkkp.dk/fhir/CodeSystem/ATC"/>
<concept>
<code value="L01BC02"/>
<display value="Fluorouracil (5-FU)"/>
</concept>
<concept>
<code value="L01BC05"/>
<display value="Gemcitabine"/>
</concept>
<concept>
<code value="L01BC06"/>
<display value="Capecitabine"/>
</concept>
<concept>
<code value="L01CA04"/>
<display value="Vinorelbine"/>
</concept>
<concept>
<code value="L01CD01"/>
<display value="Paclitaxel"/>
</concept>
<concept>
<code value="L01CD02"/>
<display value="Docetaxel"/>
</concept>
<concept>
<code value="L01CE02"/>
<display value="Irinotecan"/>
</concept>
<concept>
<code value="L01DB01"/>
<display value="Doxorubicin"/>
</concept>
<concept>
<code value="L01DB03"/>
<display value="Epirubicin"/>
</concept>
<concept>
<code value="L01FD01"/>
<display value="Trastuzumab"/>
</concept>
<concept>
<code value="L01FF01"/>
<display value="Nivolumab"/>
</concept>
<concept>
<code value="L01FF02"/>
<display value="Pembrolizumab"/>
</concept>
<concept>
<code value="L01FG01"/>
<display value="Bevacizumab"/>
</concept>
<concept>
<code value="L01XA01"/>
<display value="Cisplatin"/>
</concept>
<concept>
<code value="L01XA02"/>
<display value="Carboplatin"/>
</concept>
<concept>
<code value="L01XA03"/>
<display value="Oxaliplatin"/>
</concept>
<concept>
<code value="S01LA08"/>
<display value="Bevacizumab"/>
</concept>
</include>
<include>
<system value="https://kip.rkkp.dk/fhir/CodeSystem/GenericValues"/>
<concept>
<code value="other"/>
<display value="Andet"/>
</concept>
</include>
</compose>
</ValueSet>